Jakarta, Indonesia, July 2, 2013 - (ACN Newswire) - Indonesia's only vaccine and antisera producer Bio Farma is holding the country's 3rd national vaccine research forum (NVRF) on 2-3 July in Jakarta.
Bio Farma Corporate Secretary M. Rahman Rustan said today this year's NVRF is held as a part of the company's 123rd anniversary program, with the attendance of vaccine experts Professor Julie Bines from the Murdoch Children's Research Institute (MCRI) Australia and Professor Keiko Udaka of Kochi Medical School Japan.
Rustan explained the initiative of Bio Farma in organizing NVRF has received positive response from Indonesia's Ministry of Research and Technology and Ministry of Health's Agency for Health Research and Development.
The theme for this year's forum is "The Strengthening of National Vaccine Research within the Framework of V Self-reliance in Vaccine, through NVRF, Towards the Decade of Vaccine 2011-2020". This proposition serves for a collaboration between industry, government and universities to build a shared commitment to the independence of national vaccine research and production.
Another goal of the event, attended by some 500 participants from within the country and overseas, is to accelerate vaccine research whose results can be felt and taken advantage of by the people. The participants of the forum consist of representatives from industrial circles, government, and universities.
According Rustan, the Decade of Vaccines 2011-2020 forms the basis for academia, government, and industry to align measures in order to improve and enhance the society's degree of health.
Through the Decade of Vaccines it is expected that Indonesia's self-reliance in producing quality, affordable and readily availabe vaccines will increase, and, with an ever equitable immunization for all people of all ages, Human Rights in the Health Sector will be realized.
Ramhan added, in addition to Bio Farma president director Iskandar, the resource persons from Indonesia during this 3rd NVRF are Trihono, head of the Ministry of Health's Research and Development Agency, and the Ministry of Research and Technology's Deputy Amin Soebandrio.
During the event, there will be ceremonies for the signing of agreements between Bio Farma and third parties, and submission of the 2012 NVRF proceedings from the company to the Ministry of Research and Technology and the Ministry of Health's Research and Development Agency.
Currently, the needs for EPI vaccines in Indonesia have been supplied solely by Bio Farma by manufacturing and distributing more than 1.7 billion doses of vaccine per year to meet the needs of EPI vaccine for the national immunization program.
Bio Farma has an outstanding international reputation based on the WHO prequalification for all of its Expanded Program on Immunization vaccines (EPI) vaccine products. Bio Farma also implements green industry, and is environmently friendly. WHO prequalification successfully proves that vaccine produced by Bio Farma are of high quality, efficacious, and affordable for the Indonesian people and the world.
Bio Farma products are exported to countries around the world through direct distribution or through various agencies such as UNICEF and PAHO. Bio Farma has obtained the Best Export Performance from the Ministry of Trade in 2010, 2011, 2012 as evidence of its consistent and exceptional performance.
About PT Bio Farma (Persero)
Since its establishment in 1890, PT Bio Farma (Persero) has been active in supplying high quality vaccines and serum for people. Currently, Bio Farma is among the largest vaccines manufacturers and suppliers in the world. The need for EPI vaccines in Indonesia has been supplied solely by Bio Farma.
Bio Farma has existed for a century and proven its strength and experience world wide. The company has also grown and developed to become a vaccine and serum manufacturer of international reputation. This can be seen from its qualifications and ability to acquire WHO prequalification for all of its EPI Vaccine products. For more information, please visit www.biofarma.co.id.
M. Rahman Rustan
+62 22 2033755
+62 22 2041306
e-mail : [email protected]